Accessibility Statement Skip Navigation
  • Resources
  • Data Privacy
  • Contact Us
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • All Multimedia

        • All Multimedia
        • All Photos
        • All Videos
    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Accessories
        • Computer Hardware
        • Computer Networks
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High-Tech Security
        • Internet Technology
        • Nanotechnology
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art, Culture & Design
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Projections or Forecasts
        • Financing Agreements
        • Insurance
        • Joint Ventures
        • Mutual Funds
        • Offerings
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing/marketing agreements
        • New Products & Services
        • Obituary
        • Outsourcing Businesses
        • Overseas Real Estate (Non-US)
        • Personnel Announcements
        • Residential Real Estate
        • Small-Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Accessories
        • Computer Electronics
        • Computer Hardware
        • Computer Networks
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Design Automation
        • Financial Technology
        • Mobile Devices/Apps
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Natural Gas Utilities
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Computer Accessories
        • Computer Networks
        • Mobile Devices/Apps
        • Telecommunications
        • Telecommunications Carriers & Services
        • Telecommunications Equipment
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wine & Spirits
        • Beverages
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art, Culture & Design
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infectious Disease Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental Products & Services
        • European Government
        • Natural Disasters
        • Not-for-Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Children-related news
        • Disabled Persons
        • Diversity, Equity & Inclusion
        • Hispanic-oriented news
        • LGBTQ+
        • Religion
        • Senior Citizens
        • Veterans
        • Women-Related news
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Request a Demo
    • Partnerships
    • Media Inquiries
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring Home
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us


    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • News Releases
      • Send a Release
      • Data Privacy
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • News Releases
      • Send a Release
      • Data Privacy
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • News Releases
      • Send a Release
      • Data Privacy
      • General Inquiries
      • Request a Demo
      • Partnerships
      • Media Inquiries
      • Editorial Bureaus
      • News Releases
      • Send a Release
      • Data Privacy
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • All Multimedia
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Daripada Keputusan Kiraan Darah Lengkap kepada Imej Sel: Ozelle Memperagakan O-Cyte 1 di MEDICA 2026

      • USA - English
      • India - English
      • MEXICO - Spanish
      • USA - Français
      • USA - Deutsch
      • Japan - Japanese
      • Korea - 한국어
      • BRAZIL - Portuguese
      • USA - español
      • APAC - Thai
      • APAC - Traditional Chinese

      News provided by

      Ozelle

      16 Nov, 2026, 17:45 CST

      Share this article

      Share this article


      DÜSSELDORF, Jerman, 16 November 2026 /PRNewswire/ -- Apabila ujian kiraan darah lengkap (CBC) mengesan penemuan luar biasa, pemerhatian terhadap sel dapat memberikan konteks yang bernilai untuk pemeriksaan lanjut. Pada MEDICA 2026, Ozelle memperagakan O-Cyte 1, penganalisis hematologi automatik yang mengintegrasikan pengimejan sel beresolusi tinggi ke dalam ujian CBC rutin.

      Continue Reading
      Ozelle mempamerkan rangkaian penganalisis hematologi berasaskan AI dan sistem diagnostik bersepadu di MEDICA 2026, dengan menonjolkan keupayaan pengimejan sel terbina dalam serta analisis morfologi berbantukan AI.
      Ozelle mempamerkan rangkaian penganalisis hematologi berasaskan AI dan sistem diagnostik bersepadu di MEDICA 2026, dengan menonjolkan keupayaan pengimejan sel terbina dalam serta analisis morfologi berbantukan AI.

      Teknologi AI × CBM (Complete Blood Morphology) Ozelle menggabungkan pengimejan sel dengan analisis morfologi berbantu AI. O-Cyte 1 menyepadukan keupayaan ini dengan pembezaan sel darah putih kepada tujuh kategori. Imej sel yang dirakam semasa ujian automatik tersedia bersama-sama keputusan CBC untuk diteliti oleh profesional makmal apabila penilaian morfologi lanjut diperlukan.

      Di makmal yang sibuk, maklumat tambahan tersebut perlu disesuaikan dengan aliran kerja ujian sedia ada. O-Cyte 1 menyokong pemuatan kelompok sebanyak 25 tiub, pengenalpastian sampel secara automatik melalui kod bar dan pencampuran sampel secara automatik, pensampelan daripada tiub tertutup serta pemprosesan keutamaan bagi ujian segera (STAT). Satu unit penganalisis yang beroperasi secara kendiri boleh memproses sehingga 60 ujian sejam, manakala enam unit yang disambungkan mampu mencapai sehingga 360 ujian sejam, membolehkan makmal meningkatkan kapasiti apabila beban kerja bertambah.

      Penyelenggaraan rutin merupakan satu lagi pertimbangan praktikal. Penganalisis konvensional yang mempunyai laluan bendalir dalaman boleh guna semula memerlukan pembersihan berkala. Sebaliknya, O-Cyte 1 menyepadukan komponen utama yang bersentuhan dengan bendalir ke dalam kit reagen yang boleh diganti, sekali gus membantu mengurangkan keperluan pembersihan di bahagian dalam instrumen. Pemeriksaan kendiri terbina dalam dan modul yang boleh diganti memudahkan penyelesaian masalah serta kerja penyelenggaraan, di samping membantu pengedar menyediakan sokongan selepas jualan.

      "Kami mahu menjadikan morfologi sel sebahagian daripada ujian CBC rutin sambil memastikan aliran kerja makmal kekal cekap," kata Jie Du, Pengasas Bersama dan Ketua R&D di Ozelle. "Ini bermakna kami perlu mereka bentuk keseluruhan sistem dengan mengambil kira pengendalian sampel, semakan imej dan penyelenggaraan."

      Bagi klinik dan pusat ujian terpencar, keutamaannya ialah menyediakan rangkaian ujian yang lebih luas dalam ruang terhad dengan keperluan penyelenggaraan yang lebih rendah. Siri penganalisis kompak EHBT Ozelle untuk penjagaan kesihatan manusia merangkumi hematologi, pengimejan sel, imunoasai dan biokimia kering. Siri veterinar EHVT pula menawarkan ujian hematologi, morfologi sel digital, imunoasai, biokimia, air kencing dan najis. Kedua-dua rangkaian produk menekankan prestasi yang boleh dipercayai, pengendalian yang mudah dan penyelenggaraan rutin yang minimum.

      Demonstrasi secara langsung diteruskan sehingga 19 November di Dewan 1, Reruai D63, Messe Düsseldorf. Pengunjung boleh menyaksikan penganalisis tersebut beroperasi dan membincangkan aplikasi klinikal serta peluang pengedaran. Untuk mengatur pertemuan atau demonstrasi produk, hubungi pasukan Ozelle.

      Ketahui Lebih Lanjut Mengenai Ozelle

      www.ozellemed.com
      [email protected]

      SOURCE Ozelle

      Modal title

      Also from this source

      Ozelle สาธิต O-Cyte 1 ในงาน MEDICA 2026 ยกระดับผลตรวจความสมบูรณ์ของเม็ดเลือดด้วยภาพเซลล์

      Ozelle สาธิต O-Cyte 1 ในงาน MEDICA 2026 ยกระดับผลตรวจความสมบูรณ์ของเม็ดเลือดด้วยภาพเซลล์

      เมื่อผลการตรวจความสมบูรณ์ของเม็ดเลือด (Complete Blood Count: CBC) บ่งชี้ความผิดปกติ...

      Ozelle เตรียมนำเสนอ O-Cyte 1 ในงาน MEDICA 2026 ชูระบบตรวจวิเคราะห์ทางโลหิตวิทยาที่ใช้ AI ช่วยวิเคราะห์และรองรับการขยายกำลังการตรวจ

      Ozelle เตรียมนำเสนอ O-Cyte 1 ในงาน MEDICA 2026 ชูระบบตรวจวิเคราะห์ทางโลหิตวิทยาที่ใช้ AI ช่วยวิเคราะห์และรองรับการขยายกำลังการตรวจ

      เมื่อการวิเคราะห์สัณฐานวิทยาของเซลล์ด้วย AI ถูกนำมาใช้ในงานโลหิตวิทยาประจำวันมากขึ้น ห้องปฏิบัติการจึงต้องการมากกว่าการจำแนกเซลล์อัตโนมัติ...

      More Releases From This Source

      Explore

      Medical Equipment

      Medical Equipment

      Health Care & Hospitals

      Health Care & Hospitals

      Artificial Intelligence

      Artificial Intelligence

      Trade Show News

      Trade Show News

      News Releases in Similar Topics

      Contact PR Newswire

      • General Inquiries
      • Request a Demo
      • Partnerships
      • Media Inquiries

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Become a Publishing Partner
      • Careers
      • Accessibility Statement
      • APAC – Simplified Chinese
      • APAC
      • APAC - Traditional Chinese
      • Arabic
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • United States
      • Vietnam

      My Services

      • All New Releases
      • Platform

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact Cision

      Products

      About

      My Services
      • All News Releases
      • Platform
      [email protected]
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      • Accessibility
      Copyright © 2026 Cision US Inc.